4
Changes in Ownership
Aprea Therapeutics, Inc. Filed Acc 0001104659-24-108375
President/CEO bought 1,150 shares at an average $2.58 ($2,971)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Gilad Oren President/CEO | 2024-10-10 | Purchase | +150 | $2.54 | $381 | 331,645 | D |
| Gilad Oren President/CEO | 2024-10-14 | Purchase | +1,000 | $2.59 | $2,590 | 332,645 | D |
| Open-market purchases · 1,150 sh · avg $2.58 · $2,971 | |||||||
Loading xslF345X05/tm2426059-3_4seq1.xml…